ReviewMikrochimica acta2024
MXene-based electrochemical devices applied for healthcare applications.
Review in Mikrochimica acta, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 55 citations in OpenAlex.
- The versatile world of MXene nanohybrids: designed synthesis, functional diversity, and promising theranostics.Mikrochimica acta · 2026Review
- New Perspective on Functionalized Metal Nanoparticles and Two-Dimensional Nanomaterials-Based Composites for Electrochemical Biomarker Sensing and Energy Storage Devices.Chemical record (New York, N.Y.) · 2026Review
- ITO-PET electrochemical biosensor functionalized with carboxylated graphene oxide for prostate cancer biomarker detection.Scientific reports · 2026Article
- Unraveling the Potential of MXenes in Electrochemical Sensing: Mechanistic Insight, Design Principles, and Analytical Applications.Small science · 2026Review
- Article
- Pseudo-two-dimensional multiphysics modeling of mass transport and pseudo-enzymatic kinetics in TiRSC advances · 2026Article
- Two-Dimensional MXenes as Next-Generation Nanomaterials for Biosensing and Hydrogen Production.Nanotechnology, science and applications · 2026Review
- The Future of MXene Fibers.Advanced materials (Deerfield Beach, Fla.) · 2025Article
- Development and synthesis of DNA-based label-free electrochemical biosensor for detection of Enterocytozoon bieneusi using screen-printed gold electrode.BMC chemistry · 2025Article
- Advances in MXene-Based Electrochemical Sensors for Multiplexed Detection in Biofluids.International journal of molecular sciences · 2025Review
- Recent Advancements in MXene-Based Biosensors for Health and Environmental Applications-A Review.Biosensors · 2024Review
- Review
- Recent Progress in Wearable Near-Sensor and In-Sensor Intelligent Perception Systems.Sensors (Basel, Switzerland) · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 4 institutions in 2 countries.
Funding
Abstract
The initial part of the review provides an extensive overview about MXenes as novel and exciting 2D nanomaterials describing their basic physico-chemical features, methods of their synthesis, and possible interfacial modifications and techniques, which could be applied to the characterization of MXenes. Unique physico-chemical parameters of MXenes make them attractive for many practical applications, which are shortly discussed. Use of MXenes for healthcare applications is a hot scientific discipline which is discussed in detail. The article focuses on determination of low molecular weight analytes (metabolites), high molecular weight analytes (DNA/RNA and proteins), or even cells, exosomes, and viruses detected using electrochemical sensors and biosensors. Separate chapters are provided to show the potential of MXene-based devices for determination of cancer biomarkers and as wearable sensors and biosensors for monitoring of a wide range of human activities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.